Search FHI 360

Start a New Search

Search within these results

NewsU.S. HIV programsHealth

14 Results Found

News

Study identifies ways to increase HIV testing, reduce HIV infection and detect previously undiagnosed HIV infections

Study results presented today at the Conference on Retroviruses and Opportunistic Infections by the HIV Prevention Trials Network (HPTN) and the National Institutes of Health (NIH) show that a series of community efforts can increase the number of...
News

FHI 360 commends PEPFAR Blueprint release

RESEARCH TRIANGLE PARK, NC — FHI 360 applauds today's release of the PEPFAR Blueprint: Creating an AIDS-free Generation. This document provides a roadmap for how the U.S. government will work with partners to help achieve an AIDS-free generation...
News

Advancing Partners and Community-Based Family Planning Grant awarded to JSI, FHI 360

RESEARCH TRIANGLE PARK, NC — FHI 360 has been named a technical partner in the Advancing Partners and Community-Based Family Planning Cooperative Agreement that the U.S. Agency for International Development has awarded to JSI Research and Training...
News

Final results of FEM-PrEP HIV-prevention study indicate great attention to adherence will be required in PrEP programs

RESEARCH TRIANGLE PARK, NC — Results of the FHI 360 FEM-PrEP HIV-prevention trial reinforce the key role of adherence in HIV-prevention studies and the need to determine better approaches to support adherence in future pre-exposure prophylaxis (PrEP...
News

FHI 360 senior scientist Lut Van Damme receives International Microbicide Conference Lifetime Achievement Award

RESEARCH TRIANGLE PARK, NC — In recognition of her many significant contributions to the field of HIV prevention, FHI 360 Senior Scientist Lut Van Damme, MD, PhD received a Lifetime Achievement Award this week at the 2012 International Microbicides...
News

'Science' names HIV prevention trial as breakthrough of the year

RESEARCH TRIANGLE PARK, NC — Today, Science named the HIV Prevention Trials Network (HPTN) 052 study "Breakthrough of the Year." FHI 360 congratulates our HPTN 052 collaborating partners on this important achievement. This is the second year in a...
News

VOICE HIV prevention trial discontinues Tenofovir gel arm

RESEARCH TRIANGLE PARK, NC — The Microbicides Trials Network (MTN) announced today that it will discontinue testing tenofovir vaginal gel in the HIV prevention trial VOICE (Vaginal and Oral Interventions to Control the Epidemic). This decision came...
News

UNICEF and FHI 360 renew global memorandum of understanding

ARLINGTON, VA — UNICEF signed a Memorandum of Understanding (MOU) with FHI 360 to strengthen cooperation and support in improving the lives of children and their families through policy, advocacy, programs and research in global health and...
News

Pre-exposure prophylaxis trials demonstrate effectiveness in preventing HIV infection among heterosexuals

RESEARCH TRIANGLE PARK, NC — Results announced today by the two clinical trial teams, Partners PrEP and TDF2, provide the first evidence that HIV infection among heterosexuals can be prevented by taking an oral, once-daily tablet. Pre-exposure...
News

Anti-HIV gel leadership team acknowledged for outstanding achievement in world health

CHICAGO, IL — Today the CAPRISA 004 study leadership team is being awarded the inaugural Drug Information Association (DIA) President's Award for Outstanding Achievement in World Health. The award recognizes the team's significant contribution to...

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Study identifies ways to increase HIV testing, reduce HIV infection and detect previously undiagnosed HIV infections

FHI 360 commends PEPFAR Blueprint release

Advancing Partners and Community-Based Family Planning Grant awarded to JSI, FHI 360

Final results of FEM-PrEP HIV-prevention study indicate great attention to adherence will be required in PrEP programs

FHI 360 senior scientist Lut Van Damme receives International Microbicide Conference Lifetime Achievement Award

'Science' names HIV prevention trial as breakthrough of the year

VOICE HIV prevention trial discontinues Tenofovir gel arm

UNICEF and FHI 360 renew global memorandum of understanding

Pre-exposure prophylaxis trials demonstrate effectiveness in preventing HIV infection among heterosexuals

Anti-HIV gel leadership team acknowledged for outstanding achievement in world health